Track the 바스칸바이오제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바스칸바이오제약 has recorded 19 public disclosures. Market capitalisation: €33.5bn. The latest transaction was disclosed on 30 March 2026 (Sale). Among the most active insiders: 민천기. The full history is openly available.
19
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
8 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,659 of 27,949 companies
77.9
score / 100
Value
86
Quality
70
FCF yld10%
Earn yld14%
EV/EBITDA6.5x
ROE·
Gross mgn27%
Net mgn14%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.